Skip to main content

Advertisement

Log in

A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome underlies between 2 and 5% of all colorectal cancer. It is inherited as an autosomal dominant condition due to mutations in the mismatch repair genes. Fifty-four non-related index cases, 21 of them fulfilling Amsterdam criteria I or II, were studied. Ten (10/21 = 47.6%) different pathological mutations were found in this group, two of which had not previously been reported—one in MLH1 and the other in MSH2-. In the remaining patients, we also found another family with one of these new mutations, and four additional changes, two of which were also new—a pathological change in MSH2 and a second change of uncertain significance in MLH1-, while the other two changes had already been reported. Of all mutations, eight were found in MSH2 (8/15 = 53.3%) and seven in MLH1 (7/15 = 46.6%), suggesting a slightly greater involvement of MSH2 in HNPCC than MLH1 in our population, in contrast to the results reported by other authors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

MMR:

Mismatch repair

HNPCC:

Hereditary non-polyposis colorectal cancer

CRFC:

Colorectal cancer

InSIGHT database:

International society for gastrointestinal hereditary tumours

CSGE:

Conformational-sensitive gel electrophoresis

MLPA:

Multiple ligation probe amplification

References

  1. Piñol V, Andreu M, Castells A et al (2004) Frequency of hereditary nonpolyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study. Eur J Gastroenterol Hepatol 16(1):39–45

    Article  PubMed  Google Scholar 

  2. Toribara NW, Sleisenger MH (1995) Screening for colorectal cancer. N Engl J Med 332:861–867

    Article  CAS  PubMed  Google Scholar 

  3. Pistorius S, Gorgens H, Plaschke J et al (2007) Genomic rerrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett 248(1):89–95

    Article  CAS  PubMed  Google Scholar 

  4. Peltomäki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10:735–740

    Article  PubMed  Google Scholar 

  5. Eng C, Brody LC, Wagner TM et al (2001) Steering committee of the breast cancer information core (BIC) consortium. Interpretation of molecular epidemiologic research: blinded comparison of methods for detecting germline BRCA1 mutation. J Med Genet 38:824–833

    Article  CAS  PubMed  Google Scholar 

  6. International Society for Gastrointestinal Hereditary Tumours (InSight), www.insight-group.org

  7. Lastella P, Surdo NC, Resta N, et al. (2006) In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects. BMC Genomics 7:243

    Google Scholar 

  8. Goecke T, Schulmann K, Engel C et al (2008) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with lynch syndrome: a report by the German HNPCC consortium. J Clin Oncol 24(26):4285–4292

    Article  Google Scholar 

  9. Goldberg Y, Porat RM, Kedar I et al (2008) Mutation spectrum in HNPCC in the Israeli population. Fam Cancer 7(4):309–317

    Article  CAS  PubMed  Google Scholar 

  10. Nytröm-Lahti N, Wu Y, Hoisio AL et al (1996) DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 5(6):763–769

    Article  Google Scholar 

  11. Wu Y, Nytröm-Lahti N, Osinga J et al (1997) MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosom Cancer 18:269–278

    Article  CAS  PubMed  Google Scholar 

  12. Barnetson RA, Cartwright N, van Vliet A et al (2008) Classification of ambiguous mutations in DNA mismatch repair genes identifies in a population-based study of colorectal cancer. Hum Mutat 29(3):367–374

    Article  CAS  PubMed  Google Scholar 

  13. Martinez-Bouzas C, Ojembarrena E, Beristain E et al (2007) High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country. Cancer Lett 255:295–299

    Article  CAS  PubMed  Google Scholar 

  14. Mangold E, Pagenstecher C, Friedl W et al (2005) Propping and the German HNPCC consortium, spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 116:692–702

    Article  CAS  PubMed  Google Scholar 

  15. Perera S, Bapat B (2008) The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation. Hum Mutat 29(2):332

    Article  PubMed  Google Scholar 

  16. Ollila S, Sarantaus L, Kariola R et al (2006) Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein. Gastroenterology 131:1408–1417

    Article  CAS  PubMed  Google Scholar 

  17. Devlin LA, Graham CA, Price JH, Morrison PJ (2008) Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than hereditary non polyposis colorectal cancer cohorts. Ulst Med J 77(1):25–30

    Google Scholar 

  18. Martinez-Bouzas C, Beristain E, Errasti J et al (2007) Nueva mutación en MLH1: c.306+5G>A produce un nuevo sitio de splice en una familia con cáncer de colon no poliposico. Paper presented at the XXIV Congreso Nacional de Genética Humana. Alicante 19–21 Septiembre 2007

  19. Pineda M, Blanco I, Llort G et al (2007) Identificación de dos mutaciones recurrentes en MLH1 en nuestra población. Paper presented at the XXIV Congreso Nacional de Genética Humana. Alicante 19–21 Septiembre 2007

  20. Ewald J, Rodrigue CM, Mourra N et al (2007) Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer. Br J Surg 94(8):1020–1027

    Article  CAS  PubMed  Google Scholar 

  21. Belvederesi L, Bianchi F, Loretelli C et al (2006) Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. Eur J Hum Genet 14:853–859

    Article  CAS  PubMed  Google Scholar 

  22. Blasi MF, Ventura I, Aquilina G et al (2006) A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. Cancer Res 66(18):9036–9044

    Google Scholar 

  23. Wagner A, Barrows A, Wijnen JT et al (2003) Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 72:1088–1100

    Article  CAS  PubMed  Google Scholar 

  24. Taylor CF, Charton RS, Burn J, Sheridan E, Taylor GR (2003) Genomic delections in MSH2 or MLH1 are a frequent cause of hereditary nonpolyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat 22:428–433

    Article  CAS  PubMed  Google Scholar 

  25. Gile JJ, Hogervost FB, Pals G et al (2002) Genomic delections of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892–897

    Article  Google Scholar 

  26. Picelli S, Vandrovcova J, Jones S et al (2008) Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q. BMC Cancer 8:87

    Article  PubMed  Google Scholar 

  27. Bläker H, Mechtersheimer G, Sutter C et al (2008) Recurrent deletions at 6q in early age of onset non-HNPCC and non-FAD associated intestinal carcinomas. Evidence for novel cancer susceptibility locus at 6q14–q22. Genes Chromosom Cancer 47:159–164

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants: (a) 200411060 from the Department of Health of the Basque Government and (b) BI0O7/CA/006 from Basque Foundation for Health Innovation and Research.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Cristina Martínez-Bouzas or Maria Isabel Tejada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martínez-Bouzas, C., Beristain, E., Ojembarrena, E. et al. A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations. Familial Cancer 8, 533–539 (2009). https://doi.org/10.1007/s10689-009-9283-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-009-9283-3

Keywords

Navigation